Will be interested in this when it reports 👍. Cochrane are super robust. https://t.co/XyXO9l38S4
RT @AtsushiMizuno3: It finally begins!! Please wait our results!! Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agon…
これは是非知りたい。期待通りの結果になるか、ACCORDみたいに塩辛い結果になるか。 僕はSGLT2iに3000点
RT @AtsushiMizuno3: It finally begins!! Please wait our results!! Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agon…
RT @AtsushiMizuno3: It finally begins!! Please wait our results!! Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agon…
かなり時間かかるなぁ~と思いますが、 ようやく次のステップです!! SGLT2は楽しみです~ Protocol published! #cochrane
It finally begins!! Please wait our results!! Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis https://t.co/mDuQVZa
New protocol published: Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis https://t.co/r2FGJLgtVv @cochranecollab @Wil